When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Lizzy Lawrence leads STAT’s ...

India's pharma industry is ready to flex its generics muscle as the patent for a key ingredient of blockbuster weight-loss drugs expires today. Pharmarack estimates India’s weight-loss drug market to ...

A new study has found that generic medicines in India are just as effective as branded drugs but cost up to 14 times less, challenging entrenched perceptions about quality and value in the ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...

TARLAC CITY (PIA) — The Department of Health (DOH) Central Luzon Center for Health Development (CLCHD) supports the use of generic medicines as an alternative to branded ones, as part of its strategy ...

The High Court's recent judgement in Generics (UK) Limited v Astrazeneca AB (EWHC 2203 (Pat)) has established important precedents regarding cost allocation in multi-party patent disputes. Deputy ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Software development is one of the most rewarding careers in the world of IT. Java is one of the ...

Danish pharmaceutical giant Novo Nordisk is set to lose Canadian patent protection on its popular semaglutide-based drugs, Ozempic and Wegovy. (Credit: EBASTIEN BOZON/AFP via Getty Images) U.S.

Picture this: A cancer patient in a district hospital, once sent abroad for care, now begins treatment with cell therapy—developed and produced just a few hours away, in a domestic biomanufacturing ...

US President Donald Trump’s recent executive order, aimed at reducing prescription drug prices for Americans, is expected to have significant implications for the global pharmaceutical market, ...